

Image: Freepik
For decades, advice on how much vitamin C we need each day has been portrayed by government health authorities as settled science. But a new commentary published in the British Journal of Nutrition challenges this idea head-on. It argues that the UK’s current recommendation – set over 30 years ago at a mere 40 mg per day – is not properly supported by the available evidence. Drawing on a combination of overlooked clinical trials and newer analyses, the authors demonstrate that higher intakes can provide important health benefits. Crucially, they also highlight a fundamental flaw in current thinking: the idea that one single daily requirement can apply equally to everyone, regardless of lifestyle, health status, or environmental stress.
The paper adds to a growing body of scientific argument suggesting that official vitamin C guidelines are outdated and urgently in need of revision. For more than twenty years, the Dr. Rath Health Foundation has been drawing attention to precisely this same point – arguing that optimal nutrient intakes should be based on promoting full health, not merely preventing extreme deficiency diseases like scurvy. The new British Journal of Nutrition analysis provides further validation of our position.
Current recommendations fail to promote optimal health
At the heart of the issue is the methodology by which the UK’s recommendation was originally established. The current guideline dates back to 1991 and is largely based on a much older experiment from the 1950s known as the Sheffield study. That research found that as little as 10 mg of vitamin C per day was enough to prevent scurvy, a severe deficiency disease historically associated with sailors. The UK authorities then set a higher figure of 40 mg per day – not because it was shown to produce clear health benefits, but simply because it resulted in detectable levels of vitamin C in the blood.
This approach, the new commentary argues, is deeply flawed. Preventing scurvy is not the same as achieving optimal health. At the time, there was already evidence suggesting that vitamin C plays a much broader role in the body, influencing immune function, cardiovascular health, hormone production, and even gene activity. By focusing narrowly on the most visible symptoms of deficiency – such as bleeding gums and skin problems – the UK guideline ignored a wider spectrum of health effects linked to low vitamin C intake.
One of the most striking criticisms in the paper is that key clinical trials were overlooked when the recommendations were formulated. Several controlled studies published before 1991 showed that vitamin C supplementation could reduce the frequency, severity, or duration of respiratory infections – even in people already consuming 40 mg per day or more. In other words, benefits were observed well above the level considered “adequate” by UK standards.
Further analyses have reinforced these findings. Reviews of multiple trials found consistent evidence that higher doses of vitamin C – often 1,000 mg per day or more – can shorten colds and reduce their severity. In some cases, supplementation also lowered the risk of developing infections in the first place. Importantly, these studies were conducted across different countries and populations, including both adults and children.
The implication is clear: the threshold for preventing scurvy is not the same as the intake needed to support immune resilience or overall health. By failing to distinguish between these goals, current recommendations risk underestimating the true importance of vitamin C.
A ‘one-size-fits-all’ approach is scientifically outdated
The paper also revisits the Sheffield study itself, uncovering additional reasons for concern. A recent re-analysis of the original data found that individuals consuming just 10 mg of vitamin C per day had significantly weaker scar tissue compared to those consuming higher amounts. This suggests that even basic physiological processes like wound healing may be compromised at intake levels long considered “sufficient”.
Moreover, the original study reported serious health events among participants who were deprived of vitamin C, including cardiac problems and worsening of existing diseases. These findings point to an insufficient supply of the nutrient having a serious impact on the body – one that was largely ignored when official guidelines were set.
Another major theme of the commentary is the wide variation in how individuals respond to vitamin C. The authors argue that it is unrealistic to assume a single daily requirement that applies to everyone. Factors such as physical activity, stress levels, infections, smoking, and even genetic differences can all influence how much vitamin C the body needs.
For example, several studies have shown that people under intense physical stress – such as athletes or individuals exposed to extreme conditions – experience greater benefits from vitamin C supplementation. In these groups, higher intakes can significantly reduce the risk of respiratory infections. By contrast, the same effects may be less pronounced in more sedentary individuals.
This variability is not unique to vitamin C. Research on other nutrients, such as vitamin E, has similarly demonstrated that their health effects can differ widely depending on individual characteristics and lifestyle factors. Taken together, these findings make it clear that a “one-size-fits-all” approach to nutrient intake recommendations is scientifically outdated.
Biological evidence further supports this view. Vitamin C is involved in numerous processes throughout the body, including collagen production, antioxidant defence, and regulation of gene expression. These functions are influenced by changing physiological demands. During periods of stress – whether physical, environmental, or metabolic – the body’s need for vitamin C may increase significantly.
Interestingly, animals that can produce their own vitamin C naturally adjust their production levels in response to stress. This suggests that humans, who cannot synthesise the vitamin, may also require higher intakes under certain conditions. Yet current guidelines do not take this into account.
The commentary also addresses the argument that conflicting evidence makes it difficult to define optimal intake levels. The authors counter that variation in study results is not a reason to dismiss positive findings, but rather an indication that different groups have different needs. Ignoring this complexity, they argue, leads to overly simplistic recommendations that fail to serve public health.
Higher intakes offer significant health benefits
Taken as a whole, the paper presents a compelling case for re-evaluating current vitamin C guidelines. It shows that the UK’s long-standing recommendation of 40 mg per day is based on limited and outdated evidence, overlooks important clinical data, and fails to account for individual variability. It also highlights the need to focus on meaningful health outcomes – such as infection risk and recovery – rather than relying solely on biochemical markers or the prevention of extreme deficiency.
For the Dr. Rath Health Foundation, these conclusions come as no surprise. For over two decades, we have argued that optimal nutrition should be defined by what the body needs to achieve and maintain full health, not merely to avoid disease. The idea that vitamin requirements vary between individuals, and that higher intakes offer significant health benefits, is central to this thinking.
What the new British Journal of Nutrition commentary provides is further scientific reinforcement of our position. By exposing the weaknesses in current recommendations and highlighting the importance of a more evidence-based approach, it strengthens the case for updating public health guidelines. In doing so, it also raises an important question: how much longer can outdated standards continue to shape official nutritional advice in the face of growing evidence of their shortcomings?
Regardless of how the scientific orthodoxy responds to this challenge, one thing is already clear. Vitamin C is not just a protector against scurvy – it is a vital nutrient with far-reaching effects on human health. Recognising this reality, and adjusting official government intake recommendations accordingly, is long overdue.